Form 4 for TWST Twist Bioscience Corp
Accepted 2021-12-23 00:00:00 ET · period of report 2021-12-21 · accession 0001214659-21-013608 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-23 | 2021-12-21 | TWST | Finn Patrick John | Chief Commercial Off | S - Sale+OE | $82.85 | -219 | 38.2K | -0.6% | -$18.1K |
| D | 2021-12-23 | 2021-12-21 | TWST | Finn Patrick John | Chief Commercial Off | M - OptEx | $23.33 | +219 | 38.5K | +0.6% | +$5,109 |
| D | 2021-12-23 | 2021-12-21 | TWST | Finn Patrick John | Chief Commercial Off | M - OptEx | $0.00 | -219 | 20.0K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-21 | S | D | 219 | $82.85 | 38,234 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-21 | M | A | 219 | $23.33 | 38,453 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2021-12-21 | M | D | 219 | $0.00 | 19,985 | D | $23.33 · — to 2029-10-23 | 219 Common Stock | (F2) 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |